Versigent (NYSE:VGNT) Upgraded to “Strong-Buy” at The Goldman Sachs Group

The Goldman Sachs Group upgraded shares of Versigent (NYSE:VGNT) to a strong-buy rating in a research report report published on Monday morning,Zacks.com reports.

Several other research analysts also recently commented on the stock. TD Cowen raised their price objective on shares of Versigent from $47.00 to $49.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Morgan Stanley began coverage on Versigent in a research report on Friday, May 8th. They set an “overweight” rating and a $51.00 target price on the stock. Royal Bank Of Canada raised their price target on Versigent from $34.00 to $41.00 and gave the stock a “sector perform” rating in a report on Monday, July 13th. Evercore reiterated an “outperform” rating and issued a $60.00 price target on shares of Versigent in a research report on Monday, May 18th. Finally, Zacks Research upgraded Versigent from a “hold” rating to a “strong-buy” rating in a research report on Thursday, July 2nd. Three equities research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, Versigent has a consensus rating of “Buy” and an average price target of $49.60.

Versigent Price Performance

VGNT opened at $39.97 on Monday. The stock has a 50-day simple moving average of $43.46. Versigent has a twelve month low of $26.34 and a twelve month high of $50.88.